Osimertinib Mesylate
Price:Negotiable
Contact Info
- Add:Room 401, Building C6, Optics Valley Biological City, No. 666 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Zip:
- Contact: 黄经理
- Tel:027-87405925
- Email:sales@jinonpharma.com
Other Products
Description
Additional Information
| Product Name: | Osimertinib Mesylate |
| CAS: | 1421373-66-1 |
| Molecular Formula: | C28H33N7O2.CH4O3S |
| Chemical Structural Formula: |  |
| Remarks: | AstraZeneca's new drug for non-small cell lung cancer, an orally administered kinase inhibitor used for the treatment of specific types of advanced non-small cell lung cancer. It is indicated for patients whose tumors have an epidermal growth factor receptor (EGFR) T790M mutation and who have progressed after treatment with another EGFR-blocking therapy. Osimertinib is the first drug approved for this patient population and is a third-generation tyrosine kinase inhibitor (TKI). |
| Industry Category | Health & Medical/Pharmaceuticals & Raw Materials/Chemical APIs |
|---|---|
| Product Category | |
| Brand: | 珺龙 |
| Spec: | |
| Manufacturer: | 珺龙生物科技（武汉）有限公司 |
